New lupus injection shows promise in early safety trial
NCT ID NCT06955598
First seen Jan 04, 2026 · Last updated Jun 03, 2026 · Updated 25 times
Summary
This early-stage study tested the safety of a new drug called SHR-2173 in 30 adults with systemic lupus erythematosus (SLE). Participants received multiple injections under the skin to see if the drug is safe and how the body processes it. The goal is to eventually help control lupus symptoms and improve daily life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Renji Hospital affiliated to Shanghai Jiaotong
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.